Results 91 to 100 of about 3,216,105 (293)

Rheumatoid arthritis and spondyloarthropathy [PDF]

open access: yes, 2013
Part 2 of the article can be found through this link: https://www.um.edu.mt/library/oar//handle/123456789/13280Rheumatoid arthritis (RA) and spondyloarthropathy are two groups of inflammatory joint disease.
Vassallo, Pierre
core  

Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification. [PDF]

open access: yes, 2009
There is evidence that the prevalence of migraine in children and adolescents may be increasing. Current theories of migraine pathophysiology in adults suggest activation of central cortical and brainstem pathways in conjunction with the peripheral ...
A Ferrari   +52 more
core   +1 more source

Late‐Onset Spondylarthritis Presenting as Glucocorticoid‐Resistant Polymyalgia Rheumatica: A hitherto underappreciated entity where TNF or IL‐17 Blockade may have a Therapeutic Role

open access: yesArthritis &Rheumatology, Accepted Article.
Background Polymyalgia rheumatica (PMR) is an age‐related inflammatory disease with shoulder‐hip girdle involvement. Magnetic resonance imaging (MRI) reveals extracapsular/entheseal soft tissue involvements in both PMR and spondyloarthritis (SpA) with sacroiliac joint and peri‐entheseal spinal bone marrow oedema (BMO) being characteristic of SpA ...
Kerem Abacar   +12 more
wiley   +1 more source

Interações medicamentosas: uma contribuição para o uso racional de imunossupressores sintéticos e biológicos Drug interactions: a contribution to the rational use of synthetic and biological immunosuppressants

open access: yesRevista Brasileira de Reumatologia, 2011
Interação medicamentosa é um evento clínico em que os efeitos de um fármaco são alterados pela presença de outro fármaco, fitoterápico, alimento, bebida ou algum agente químico ambiental.
Luiza Cristina Lacerda Jacomini   +1 more
doaj   +1 more source

Comparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System [PDF]

open access: yes, 2016
Aim: Biological disease-modifying antirheumatic drugs (bDMARDs) are used to treat rheumatoid arthritis (RA) with adalimumab and etanercept the most used bDMARDs in Brazil.
Acurcio, Francisco De Assis   +8 more
core   +1 more source

Prescription drug use in breastfeeding mothers and infant exposure: A register‐based cohort study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Breast milk is the optimal infant nutrition; however, many infants may be exposed to prescription drugs if used by their mothers during breastfeeding. The aim of this study was to evaluate the prevalence and patterns of prescription drug use among breastfeeding mothers and to assess the availability of relative infant dose information for
Ditte Resendal Gotfredsen   +5 more
wiley   +1 more source

A cross-sectional survey of hepatitis B virus screening in patients who received immunosuppressive therapy for rheumatoid arthritis in Japan

open access: yesJournal of Pharmaceutical Health Care and Sciences
Background Patients with a history of hepatitis B virus (HBV) infection who are receiving immunosuppressive therapy are at risk of HBV reactivation and disease.
Yuki Yanagisawa   +3 more
doaj   +1 more source

A Review of Ankylosing Spondylitis [PDF]

open access: yes, 2017
Ankylosing spondylitis (AS) is a systemic autoimmune disorder that induces ankylosis of the spine (fusion of the vertebrae at their various joints) and inflammatory arthritis of peripheral joints among other symptoms.
Owen, Hannah L
core   +1 more source

Impact of diclofenac risk minimization measures addressing cardiovascular risk on analgesic use in musculoskeletal disorders

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims In 2013, risk minimization measures (RMMs) were introduced in Europe to address the increased cardiovascular risk linked to diclofenac. This study aimed to assess the impact of those RMMs on analgesic use. Methods Primary care data from CPRD GOLD (UK) were used.
Tomas Lasys   +5 more
wiley   +1 more source

Perfil dos usuários de anticitocinas disponibilizadas pelo Sistema Único de Saúde no estado do Paraná para o tratamento da artrite reumatoide Profile of users of anticytokines off ered by the health care system in the state of Paraná for the treatment of rheumatoid arthritis

open access: yesRevista Brasileira de Reumatologia, 2012
INTRODUÇÃO: O tratamento da artrite reumatoide (AR) no âmbito do Sistema Único de Saúde (SUS) tem financiamento do Ministério da Saúde e cofinanciamento das Secretarias Estaduais.
Astrid Wiens   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy